060107 - Investigator Fees or Payments
Research payments
$2,662,699
Through program year 2021, $2,662,699 in research payments was reported against 060107 - Investigator Fees or Payments, across 21 payments, paid by Bayer HealthCare Pharmaceuticals Inc..
- Paid by
- Bayer HealthCare Pharmaceuticals Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $56,621 | 2 |
| 2020 | Research | $990,589 | 3 |
| 2019 | Research | $1,615,489 | 16 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Paul Mathew Boston, MA Named on 3 payments
- Kim Kerr San Diego, CA Named on 3 payments
- Axel Grothey Germantown, TN Named on 2 payments
- Sukhmani Padda Stanford, CA Named on 2 payments
- Daniel Nobrega Da Costa Dallas, TX Named on 1 payment
- Gregory Zaharchuk Stanford, CA Named on 1 payment
- Thomas Polascik Durham, NC Named on 1 payment
- Ajjai Alva Ann Arbor, MI Named on 1 payment
- Nicole Leboeuf Worcester, MA Named on 1 payment
- Weijing Sun Philadelphia, PA Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.